Our science
We have 30 years’ experience in translating research into new drugs and diagnostics.
Our capabilities and expertise ensure seamless progress for your research, with a strong commitment to preserving your IP. We also offer tailored strategic advice and can connect you with commercial and not-for-profit partners and patient groups.
Our scientific capabilities
Therapeutics
Over 30 years’ experience in antibody humanisation, alongside expert capabilities in antibody discovery and small molecule drug discovery.
Diagnostic development
We support proof of concept through design and development, including clinical studies at our labs in Edinburgh is certified to ISO 13485.
Supporting functions and technologies
We develop and provide technologies and functions that support innovative science.
Induced pluripotent stem cell (iPSC) technology*
Our gold-standard iPSC models for neurodegeneration are essential for effective mode of action (MOA), target validation and drug discovery projects.
Microbiology
Our established facilitates and technologies can support the study of mode of action (MOA), antibiotic resistance and drug screening.
Data science*
Our long-established technologies include methods to understand structure-activity relationships or use protein structures to design new molecules. We’re expanding into new areas, including AI and machine learning.
* capability or platform in development
Other ways we can support your science
We partner with academics, early-stage biotechs, charities, healthcare professionals and industry.
Funding
Early ventures investment
IP protection and
tech transfer
Some of our partnerships
Latest news
-
LifeArc joins public involvement pledge to improve health research
-
Newborn screening programme a big step forward for rare disease research